Sanofi-aventis Announces Second Quarter 20... (y solid growth of key pharmaceutical bra...)

Sanofi-aventis Announces Second Quarter 2009 Results

Date:7/29/2009

y solid growth of key pharmaceutical brands and vaccines, strong sales in Emerging Markets and recent acquisitions. Multaq has just been launched in the U.S. in July. The strong progression of our earnings has led us to raise our guidance for 2009 to EPS(4) growth of around 10%. Since the beginning of the year, we have launched a new R&D approach to increase innovation, we have strengthened our growth platforms through acquisitions, and we are moving forward with the transformation of our company. Those achievements constitute another step toward our vision of becoming a leading diversified global healthcare company, with a sustainable growth profile by 2013".

(3) Closing expected in Q3 2009 (4) Adjusted EPS excluding selected items, at constant exchange rates and barring major adverse events

2009 second-quarter and first-half net sales

Unless otherwise indicated, all sales growth figures in this press release are stated at constant exchange rates.

In the second quarter of 2009, sanofi-aventis generated net sales of euro 7,438 million, an increase of 11.2% on a reported basis. Exchange rate movements had a favorable effect of 4.7 points, with the appreciation of the U.S. dollar (and to a lesser extent the yen) against the euro more than offsetting the unfavorable effects of some other currencies. At constant exchange rates, and after taking account of changes in structure (in particular the consolidation of Zentiva), net sales rose by 6.5%. Excluding changes in structure and at constant exchange rates, second-quarter net sales growth was 3.7%.

In the first half of 2009, sanofi-aventis posted net sales of euro 14,545 million, an increase of 6.7%. Exchange rate movements, primarily the appreciation of the U.S. dollar against the euro, had a favorable effect of 3.6 points. At constant exchange rates, and after taking account of changes in stru
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
4. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
5. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
6. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
7. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
8. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
9. Sanofi-aventis U.S. Announces Settlement of Medicaid Best Price Investigation
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26

Post Your Comments:

(Date:6/19/2013)... , June 19, 2013 MO BIO ... and other challenging microbial nucleic acid purification, announces ... Kit, for extraction of pure protein from all ... coincides with the 20 th anniversary of ... capabilities. (Photo: http://photos.prnewswire.com/prnh/20130619/LA32633 ) ...

(Date:6/19/2013)... 2013 Biotechnology industry pioneer Amgen (NASDAQ: ... provider BlackLine Systems and enterprise application software leader ... a webinar next week entitled "No Account Left Behind! ... SAP to Help Keep Its Account Reconciliations in Good Shape ... The webinar, geared at finance, accounting, audit and ...

(Date:6/19/2013)... Washington (PRWEB) June 18, 2013 A ... complex materials, costs and other trends will highlight technical ... Monterey, California this fall. In its 33rd year, the ... includes an exhibition of key suppliers, approximately 100 technical ... SPIE, the international society for optics and photonics ...

(Date:6/18/2013)... KONG, June 18, 2013 China Cord Blood ... "Company"), China,s leading provider of cord blood collection, laboratory ... services, today announced its preliminary unaudited financial results for ... 2013 ended March 31, 2013. Fourth ... the fourth quarter of fiscal 2013 increased by 33.3% ...

[0] MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil [0] Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations [0] ‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013

... Debiopharm Group,(Debiopharm), a global independent biopharmaceutical development ... oncology, today,announced the establishment of a Debiopharm ... Lausanne (EPFL), focusing on Signal Transduction,in Oncogenesis. ... the objective,of the chair is to leverage ...

... to generate antibodies against ... research targets provided by Sigma-Aldrich, MUNICH, Germany ... SIAL ) and MorphoSys AG (Frankfurt Stock,Exchange: MOR; ... to design, produce and distribute unique,recombinant research antibodies ...

... of,Brazil,s leading distributors of pharmaceutical products, Profarma,Distribuidora de Produtos Farmaceuticos ... results for the fourth quarter of,2007 (4Q07) and full year ... market share breaks record and reaches 12.8% which is 0.8 ... in the 3Q07 and 3.2 percentage ...

Cached Biology Technology:Debiopharm and EPFL Establish an Oncology Chair 2 Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 2 Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies 3

Debiopharm and EPFL Establish an Oncology Chair Sigma-Aldrich and MorphoSys Enter Into a Collaboration and Licensing Agreement for Recombinant Research Antibodies Profarma's Gross Revenue Reached R$ 740,4 Million in the 4th Quarter of 2007, a 40,1% Growth Over the Same Period in the Last Year

(Date:6/19/2013)... Mass. In the cover story for the journal ... colleagues at the University of Massachusetts Amherst describe a ... to study the function of individual proteins in individual ... advance should allow deeper insights into protein function, Chase ... of what that single protein does when we isolate ...

(Date:6/19/2013)... the Marine Biological Laboratory (MBL), Woods Hole, Massachusetts, ... by the American Society for Microbiology (ASM). ... and the scientists who worked there that have ... microbiology. A ceremony unveiling the plaque that ... June 22, 2013, at 4:30 pm in the ...

(Date:6/19/2013)... -- AT&T * and NEC Corporation of ... ultimate workhorse among ruggedized 4G LTE smartphones ... most ruggedized phones equipped with AT&T Enhanced ... and business-ready features. Its design is aimed at ... while also keeping up with daily life outside ...

Breaking Biology News(10 mins):UMass Amherst researchers develop powerful new technique to study protein function 2 UMass Amherst researchers develop powerful new technique to study protein function 3 Microbial diversity course designated as a 'Milestones in Microbiology' site 2 AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 2 AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 3 AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 4 AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life 5

[0] UMass Amherst researchers develop powerful new technique to study protein function [0] Microbial diversity course designated as a 'Milestones in Microbiology' site [0] AT&T and NEC Introduce Ultra-Rugged Smartphone Designed for Hard Work, Real Life

... (Vancouver November 8, 2007) Eating too much ... the levels of active testosterone and estrogen in the body, ... thats published this month in the Journal of Clinical Investigation. ... and avoid sugar. Table sugar is made of glucose and ...

... Biologists and computer scientists have appealed for more information ... it may better be used to understand the impact ... A study, funded by the Biotechnology and ... at the University of Reading and computer scientists at ...

... researchers have built a better plant, one that produces ... researchers accomplished the feat using a computer model that ... model to simulate every step of the photosynthetic process. ... of Plant Physiology, and will be presented today at ...

Cached Biology News:Too much sugar turns off gene that controls the effects of sex steroids 2 How global is the Global Biodiversity Information Facility? 2 Researchers successfully simulate photosynthesis and design a better leaf 2 Researchers successfully simulate photosynthesis and design a better leaf 3

Too much sugar turns off gene that controls the effects of sex steroids How global is the Global Biodiversity Information Facility?Researchers successfully simulate photosynthesis and design a better leaf

Bovine Brain Microvascular Endothelial Cells (BBMVEC) (>500,000 cells)...

The improved design and new mechanical solutions of Finnpipette Focus Multichannel Plus improves accuracy and precision.In these low volume multichannel pipettes, the super blow-out function ensures ...

... Physical Form: buffered aqueous solution. ... terminal galactose from complex carbohydrates and glycoproteins. ... galactose under conditions where the pH must ... live cells. Unit Definition: ...

... is specific for human cardiac troponin subunit T, ... signals responsible for contraction of cardiac muscle. It ... in human cells. It also cross-reacts with human ... Antigen: Highly purified human cardiac troponin ...

Biology Products:

BBMVEC (B840-05) from European Collection of Cell Cultures (ECACC)Finnpipette Focus Multichannel 8 channel 5-50l from Thermo Scientific Escherichia coli alpha-Galactosidase Positionally specific solution from Sigma-Aldrich Mouse Anti-Human Troponin T Monoclonal Antibody, Unconjugated, Clone 9B1 from Lab Vision